A sporadic case of central core disease.

K. Mroźek,M. Strugalska,A. Fidziańska

DOI: https://doi.org/10.1016/0022-510X(70)90052-3

1970-04-01

Journal of Neurological Sciences

Abstract:

What problem does this paper attempt to address?

Health Technology Assessment and Its Use in Drug Policies in China

X. Zhen,H. Dong

DOI: https://doi.org/10.1016/j.vhri.2018.01.010

IF: 5.156

2018-01-01

Value in Health

Abstract:ObjectiveTo review drug policies, health technology assessment (HTA), and HTA’s use in drug policies in China, to further improve the quality and efficiency of drugs.MethodsThis study draws on multiple methods. A systematic review of the literature, review of Chinese government documents and statistical handbooks, and authors’ experiences in drug policies and HTA in China were combined to achieve the objective.ResultsOf 571 studies identified in the initial search, 14 eligible articles (6 English, 8 Chinese) were finally included. On the Web site of the National Health and Family Planning Commission, the National Development and Reform Commission, and the Ministry of Human Resources and Social Security, we found that HTA or pharmacoeconomics evaluation is mentioned in recent years and its frequency has been increasing; however, there was not one hit about HTA or PE on the Web site of China Food and Drug Administration.ConclusionsThe decision makers have realized the importance and value of HTA and have tried to integrate HTA into drug policies and regulations. However, the application of HTA findings to drug policymaking is not yet widespread and there are a number of challenges in using HTA in China. Therefore, it is necessary to establish a national HTA commission and develop pharmacoeconomics guidelines to support the use of HTA in decision making. Moreover, the most important steps are to encourage technology innovation, groom more HTA experts, and build reliable databases in China.
Functional Mechanism(s) of the Inhibition of Disease Progression by Combination Treatment with Fingolimod Plus Pathogenic Antigen in a Glucose-6-phosphate Isomerase Peptide-Induced Arthritis Mouse Model.

Yuya Yoshida,N. Mikami,Y. Matsushima,F. Otani,Mai Miyawaki,Miku Takatsuji,Rie Banno,Takumi Tsuji,T. Fujita,K. Tsujikawa,T. Kohno

DOI: https://doi.org/10.1248/bpb.b14-00873

2015-08-01

Biological and Pharmaceutical Bulletin

Abstract:We previously reported that combination treatment with fingolimod (FTY720) plus antigenic peptide of glucose-6-phosphate isomerase (residues 325-339) (GPI325-339) from the onset of symptoms significantly inhibited disease progression in a mouse model of GPI325-339-induced arthritis. In this study, we investigated the mechanism(s) involved. The model mice were treated from arthritis onset with FTY720 alone, GPI325-339 alone, or the combination of FTY720 plus GPI325-339. At the end of treatment, inguinal lymph nodes (LNs) were excised and examined histologically and in flow cytometry. Levels of apoptotic cells, programmed death-1-expressing CD4(+)forkhead box P3(-) nonregulatory T cells (non-Tregs), and cytotoxic T-lymphocyte antigen 4-expressing non-Tregs in inguinal LNs were markedly increased in the combination treatment group mice. Regulatory T cells (Tregs) were also increased. These results indicate that combination treatment with FTY720 plus GPI325-339 inhibits the progression of arthritis by inducing clonal deletion and anergy of pathogenic T cells and also by immune suppression via Tregs.
OP27 Health Technology Assessment Processes, Characteristics, And Key Differences In High, Middle, And Low-Income Countries Of Asia Pacific Region

Ashish Verma

DOI: https://doi.org/10.1017/s0266462322000848

2022-12-25

International Journal of Technology Assessment in Health Care

Abstract:Introduction The healthcare sector in the Asia Pacific (APAC) region is in a period of rapid growth and exciting innovation. This has led to an increase in the number of APAC countries adopting and implementing health technology assessment (HTA) to assess the clinical, ethical, economic, and societal aspect of healthcare technology. The aim of this study is to provide an updated snapshot of the status of HTA and key differences in selected countries of APAC region. Methods HTA robustness and gap requirements, including its structure, process, use in decision-making and resource allocation processes were assessed through a review of published and gray literature for each of the selected country. A qualitative analysis was carried out by using a set of 15 principles of an International Working Group for HTA Advancement to identify the robustness and key differences in HTA based decision-making process in scoping countries. Results The finding of this study reveals that maturity of HTA determined by country-specific factors, such as presence of independent HTA agency, healthcare funding and expenditure, etcetera, and varies across the high-, middle-, and low-income countries of APAC region. Based on the study's results, HTA ecosystem of selected countries categorized into rising HTA followed by advancing and mature HTA categories. In addition to the differences in HTA structure, the influence of stakeholder engagement differs among HTA bodies. The variation in the time frame of HTA decisions was significant among countries, with a general lack of awareness and transparency among health policy decision-makers and resulted in longer time for assessment for rising HTA category compared to the advance and mature HTA categories. Conclusions The vision of a comprehensive and robust HTA system can be achieved by implementing a transparent, independent, decision-making, and strongly integrated HTA process in the region. We recommend that efforts should be directed to promote a transparent and sustainable HTA, throughout the low- and middle-income countries of APAC region which eventually, lead to more effective HTA ecosystem.

public, environmental & occupational health,health care sciences & services,medical informatics
The Development of Health Technology Assessment in Asia: Current Status and Future Trends.

Gordon Liu,Eric Q. Wu,Jeonghoon Ahn,Isao Kamae,Jipan Xie,Hongbo Yang

DOI: https://doi.org/10.1016/j.vhri.2019.08.472

2019-01-01

Value in Health Regional Issues

Abstract:Health technology assessment (HTA) has long been employed by many countries around the world, but its adoption in Asia has been slower. Only recently have a growing number of Asian countries started to implement HTA for pricing and reimbursement decisions. The objective of this article is to provide an overview of how HTA has been or is being implemented in Asia within the context of a country's existing-and often complex-coverage, reimbursement, and pricing schemes. Three countries at different stages of HTA implementation were selected as case studies: South Korea, where there is a young yet established HTA program; Japan, where a 3-year HTA pilot program has just concluded; and China, where HTA efforts are underway but have not been formally implemented. Not only do the experiences of these 3 countries well exemplify how the organization and scope of HTA can be customized to meet a country's unique healthcare needs, but they also provide the opportunity to outline some common key challenges that must be overcome to implement and develop HTA competencies and capabilities.
Differences In Evaluating Health Technology Assessment Knowledge Translation By Researchers And Policy Makers In China

Wenbin Liu,Lizheng Shi,Raymond W Pong,Hengjin Dong,Yiwei Mao,Meng Tang,Yingyao Chen

DOI: https://doi.org/10.1017/S0266462314000737

2014-01-01

International Journal of Technology Assessment in Health Care

Abstract:Objectives: The aim of this study was to examine the gaps between researchers and policy makers in perceptions and influencing factors of knowledge translation (KT) of health technology assessment (HTA) in China.Methods: A sample of 382 HTA researchers and 112 policy makers in China were surveyed using structured questionnaires. The questionnaires contained two sections: perceptions of HTA research and assessments of six-stage KT activities. Wilcoxon rank sum test was applied to compare the differences in these two sections between HTA researchers and policy makers. Multivariate linear regression was performed to explore KT determinants of HTA for researchers and policy makers separately.Results: Policy makers and researchers differed in their perceptions of HTA research in all items except collaboration in research development and presentation of evidence in easy-to-understand language. Significant differences in KT activities existed in all the six stages except academic translation. Regarding KT determinants, close contact between research unit and policy-making department, relevance of HTA to policy making, and importance of HTA on policy making were considered facilitators by both groups. For researchers, practicality of HTA report and presentation of evidence in easy-to-understand language can facilitate KT. Policy makers, on the other hand, considered an overly pedantic nature of HTA research as an obstacle to effective KT.Conclusions: Substantial gaps existed between HTA researchers and policy makers regarding the perceptions of HTA research and KT activities. There are also some differences in KT determinants by these two groups. Enhancing collaboration, promoting practicality and policy relevance of HTA research, and making HTA findings easily understood are likely to further the KT of HTA evidence.
Title : Voice Processing Abilities in Children with Autism Children with Specific Language Impairments and Young Typically Developing Children

V. Lewis,G. Collis

Abstract:
Development of Health Technology Assessment in China: New Challenges

Yingyao Chen,Yao He,Xunyouzhi Chi,Yan Wei,Lizheng Shi

DOI: https://doi.org/10.5582/bst.2018.01038

2018-01-01

BioScience Trends

Abstract:Health technology assessment (HTA) is a field of scientific policy research that adopts multidisciplinary approaches to conduct systematic evaluation of health technologies and inform decision making. Although achievements have been made by HTA activities among academics, providers, and policy makers, development of the field of HTA in China is fragmented and not yet formally integrated in health policy making processes. All stakeholders need to make more efforts to strengthen HTA knowledge translation and facilitate a decision making process that is based on evidence including HTA findings. This article reviews how the field of HTA has developed in China, analyzes what factors have been influencing China's HTA development, and proposes policy recommendations.
[Comparative characteristics of types of medical technologies assessment]

M E Holovnya-Voloskova,A G Tolkushin,E B Kornilova,A A Zavyalov

DOI: https://doi.org/10.32687/0869-866X-2020-28-s2-1168-1175

Abstract:This article presents the results obtained during the analysis of different types of health technology assessment (HTA). In the world HTA agencies can be organized at the national (federal), regional or local levels; they can have various levels of dependence on public authorities (independent, public, dependent), various sources of financing (state, mixed). The nature of the tasks and the range of powers of the institutions for HTA differ: regulatory, organizational or advisory. They themselves can initiate HTA (proactive), or they can conduct HTA at the suggestion of the applicants and analyze the quality of the HTA reports provided (reactively). HTA can be focused on economic assessment, comparative clinical assessment, as well as balanced, both on economic and comparative clinical assessments. HTA may be conducted on drugs, medical devices, and other medical technologies. The methods for conducting HTA significantly depend on its subject. In terms of the scope of the assessment, it is possible to single out full OMT, mini-OMT and express-OMT, as well as fast-track-OMT, proposed by the HTA agency in the UK. The final users of HTA (administration, suppliers, patients) and its perceptions (instrumental, conceptual, or formal) are specified. The impact of HTA on decision-making is progressively increasing, as the number of medical technologies that should be assessed to maintain budget discipline is increasing. The versatility of HTA indicates its universality and can contribute to the further expansion of its application at various levels of medical care around the world.
Health Technology Assessment of Medical Devices: Current Landscape, Challenges, and a Way Forward

Jian Ming,Yunzhen He,Yi Yang,Min Hu,Xinran Zhao,Jun Liu,Yang Xie,Yan Wei,Yingyao Chen

DOI: https://doi.org/10.1186/s12962-022-00389-6

2022-01-01

Abstract:BACKGROUND:Health Technology Assessment (HTA) has been widely recognized as informing healthcare decision-making, and interest in HTA of medical devices has been steadily increasing. How does the assessment of medical devices differ from that of drug therapies, and what innovations can be adopted to overcome the inherent challenges in medical device HTA?METHOD:HTA Accelerator Database was used to describe the landscape of HTA reports for medical devices from HTA bodies, and a literature search was conducted to understand the growth trend of relevant HTA publications in four case studies. Another literature review was conducted for a narrative synthesis of the characteristic differences and challenges of HTA in medical devices. We further conducted a focused Internet search of guidelines and a narrative review of methodologies specific to the HTA of medical devices.MAIN BODY:The evidence of HTA reports and journal publications on medical devices around the world has been growing. The challenges in assessing medical devices include scarcity of well-designed randomized controlled trials, inconsistent real-world evidence data sources and methods, device-user interaction, short product lifecycles, inexplicit target population, and a lack of direct medical outcomes. Practical solutions in terms of methodological advancement of HTA for medical devices were also discussed in some HTA guidelines and literature.CONCLUSION:To better conduct HTA on medical devices, we recommend considering multi-source evidence such as real-world evidence; standardizing HTA processes, methodologies, and criteria; and integrating HTA into decision-making.
Comparative analysis of knowledge translation of health technology assessment research between different types of research institues

Wenbin Liu,Lizheng Shi,W Pong,Hengjin Dong,Yingyao Chen

DOI: https://doi.org/10.7655/NYDXBSS20150616

2015-01-01

Abstract:Objective: To compare the differences in health technology assessment ﹙HTA﹚ knowledge translation between different types of research institutes and provide some scientific evidences to expand HTA impact in the process of policy-making. Methods: A self-administered questionnaire survey was implemented to domestic HTA researchers. Likert scores were applied to describe the situation of HTA knowledge translation. Rank-sum test was conducted to compare the differences. Results: While the differences in research utilization were not statistical significant, some significant differences were found between researchers from university and researchers not from university in the aspects of organizational knowledge translation support, research uptake process, cognition of knowledge translation, output forms of research outcomes, quality of HTA research. Conclusion: It is recommended to establish the knowledge translation support mechanism for HTA research outcomes, strengthen the collaborations and communications between HTA researchers and policy-makers, promote their cognition of HTA knowledge translation in the process of decision-making, and adopt various output forms of research outcomes more appropriately and effectively.
Health Technology Assessment Development In China

Yingyao Chen,David Banta,Zhiliu Tang

DOI: https://doi.org/10.1017/S0266462309090643

2009-01-01

International Journal of Technology Assessment in Health Care

Abstract:Objectives: This study is to review health technology assessment (HTA) development in China during the past two decades, and to facilitate further development of HTA and its integration into policy making.Methods: The study depends very much on the extensive experiences of the authors in involvement of HTA in China. In addition, literature review and Web site searching have been used to trace the process of growth of HTA in China.Results: With its rapid economic development, the Chinese health system has had many achievements in the past 30 years. However, there are some weaknesses that have developed during this period. HTA is traced back to the early 1990s in China. First, HTA knowledge transfer and establishment of HTA units were effective ways to develop HTA in China. By the end of 1990s, the policy makers of the Ministry of Health (MoH) made efforts to merge HTA with policy making to improve the quality and efficiency of health care. The main government authorities related to health technology are the State Food and Drug Administration, the Ministry of Labor and Social Security, and the MoH. Their involvements in HTA are varied.Conclusion: A technology licensure mechanism based on HTA, including technology permission for use, institution licensure, and workforce licensure, is being gradually carried out by the MoH in China. Moreover, HTA can play an important role in technology market entry, insurance benefit coverage, formulary, clinical pathway, reimbursement, and so on. There is a great opportunity for HTA to be an important part of health reform, especially to help policy makers within the health sector to make difficult decisions.
Development of Health Technology Assessment in Singapore,South Korea and Japan:Overview and Implications for China

LIU Jiaqi,CHEN Yingyao

DOI: https://doi.org/10.3969/j.issn.1006-7515.2011.01.005

2011-01-01

Abstract:With the development of economic and health care in Asian countries,Health technology assessment(HTA) plays an important role in these realms as an emerging discipline.This paper mainly reviewed the development of HTA in Singapore,South Korea and Japan,from which we can gain experience for the development of HTA in China.
Mapping of Health Technology Assessment in China: Situation Analysis and International Comparison

Yingyao Chen,Xunyouzhi Chi,Yao He,Yan Wei,Wija Oortwijn,Lizheng Shi

DOI: https://doi.org/10.1017/S0266462319000709

2019-11-19

International Journal of Technology Assessment in Health Care

Abstract:Objectives To analyze the current development of HTA in China and to identify areas for improvement, we mapped the level of HTA development in China and compared it with the level of HTA development in ten other countries using a survey instrument. Methods We launched a nationwide survey targeting different stakeholders. For this purpose, we used a validated instrument that enables mapping HTA development in a country using eight domains. The views of the respondents regarding the overall level of HTA development and for each domain were compared with the results of a mapping study that included ten countries. Results In total, we received 222 responses, 33 from policy-makers, 158 from researchers, and 31 from industry, as well as health provider representatives including 8 from hospitals, centers for disease control and prevention. We calculated the mean score for the level of HTA development. The overall HTA development for China was scored at 76.4 (out of a maximum of 146). Although the total score for China was comparable to the mean score of 75.6 among the ten countries, China scored significantly lower than the mean score of 117.0 among the three developed countries. In addition, China scored significantly lower in the domain of institutionalization compared to the other ten countries. Conclusions China needs to tackle the issue of low HTA institutionalization to strengthen the foundation of HTA development. Future government initiatives that institutionalize HTA, for example, establishing a national HTA system or consortium, will improve the development of HTA in China.

public, environmental & occupational health,health care sciences & services,medical informatics
Are Medical Device Characteristics Included in HTA Methods Guidelines and Reports? A Brief Review

Rituparna Basu,Simon Eggington,Natalie Hallas,Liesl Strachan

DOI: https://doi.org/10.1007/s40258-024-00896-y

Abstract:It is well accepted that medical devices (MDs) and procedures have several unique characteristics compared with pharmaceuticals, such as learning curve (LC), incremental innovation (II), dynamic pricing (DP), and organizational impact (OI). The objective of this study was to determine the extent to which these MD characteristics are routinely assessed by health technology assessment (HTA) agencies and incorporated in their guidelines and reports. Three approaches were taken. First, a review of the most recent HTA methods guidelines from 14 selected HTA agencies and 5 HTA networks was undertaken. Next, HTA reports from these agencies were reviewed for inclusion of MD-specific characteristics for 16 selected MDs. Finally, a narrative literature review on this topic was conducted. A total of 13 of the included HTA organizations, and some HTA networks (2/5), have published either general or MD-specific method guidelines, whilst several addressed MD-specific characteristics. NICE included all four MD characteristics in their guidelines, but this did not equate to their inclusion in published HTA evaluations. European Network HTA (EUnetHTA) described the inclusion of LC (within patient safety) and OI within their guidance. The results highlight a lack of consistency. For the narrative review, 10/149 articles identified were reviewed. Most provided recommendations on challenges faced by HTAs, proposed steps to address uncertainties around MD characteristics and reported a lack of methodological guidance for evaluating MDs. A lack of inclusion of MD characteristics in HTA is a complex interplay of several important factors. For these characteristics to become a formal part of HTA of MDs in the future, clear guidance and frameworks are required to enable manufacturers to develop appropriate evidence, and HTA practitioners to assess their impact more broadly.
The Health Technology Assessment Environment in Mainland China, Japan, South Korea, and Taiwan—Implications for the Evaluation of Diabetes Mellitus Therapies

tessa kennedymartin,beth d mitchell,k s boye,wen chen,bradley h curtis,jennifer a flynn,shunya ikeda,li liu,yen huei tarn,bongmin yang,e a papadimitropoulos

DOI: https://doi.org/10.1016/j.vhri.2014.03.001

2014-01-01

Value in Health Regional Issues

Abstract:HTA already has a key role in South Korea and Taiwan, with current systems undergoing important changes. In contrast, in mainland China and Japan, HTA is not yet formally utilized, although this appears likely to change. Several elements are important for HTA to be meaningful and impactful for DM therapies, including a clear, transparent analytical framework for HTA that includes all relevant costs and outcomes; availability of local DM epidemiologic, economic, and quality-of-life data; acceptance of modeling as a core methodology; availability of real-life patient data; and recognition of specific evidence requirements associated with biosimilars. HTA has the potential to assist payors in making informed decisions about the coverage of DM medications.
Health technology assessment and economic evaluation: Is it applicable for the traditional medicine?

Yingyao Chen

DOI: https://doi.org/10.1016/j.imr.2021.100756

IF: 4.473

2022-01-01

Integrative Medicine Research

Abstract:Gaps between limited health resources and expanding health service demands are emerging to be more and more prominent, which extremely generate the cost-effective strategies for scientific policy-making in the context of healthcare. As a systematic approach and solid tool to promote healthcare system more efficient and sustainable, health technology assessment (HTA) could provide multi-dimensional evidences comprising effectiveness, safety, economic implications, ethical, social, cultural and legal issues, in which economic evaluation is an important and unique part for optimizing decision-making. After decades of development, HTA has formulated a set of systematic theories, methods and procedures based on modern medicine. Meanwhile, as an important component of medicine system across the world, traditional medicine (TM) originates from knowledge, skill, and practices based on the theories, beliefs, and experiences indigenous to different traditional cultures. Yet whether current theory and method system of HTA is applicable for TM is necessary to be explored and investigated. In principle, the general steps and methods of HTA could be basically applicable to TM, except for the PICO structuring, cost measurement, and supportive clinical evidence and information collection in economic evaluation. Therefore, these three challenging problems need to be focused and addressed in future HTA for TM. (C) 2021 Published by Elsevier B.V. on behalf of Korea Institute of Oriental Medicine.
Analysis on guiding principles of hospital-based health technology assessment

Jin-song GENG,Yi CAO,Jiang-jiang HE,Da HE,Hai-yin WANG,Chun-lin JIN,Shan-lian HU

DOI: https://doi.org/10.13688/j.cnki.chr.2018.17659

2018-01-01

Abstract:Hospital-based health technology assessment(HB-HTA) is helpful for optimizing resource allocation in hospitals and increasing operational efficiency. The guiding principles for HB-HTA was analyzed according to the following aspects,organizational models,types of reports,information need of decision-makers and the attributes of technology regarding assessment,as well as the core principles for HB-HTA units. It is suggested that the requirement of decision-makers and the availability of relevant resources be considered to determine the type of HB-HTA. Multiple attributes of health technology need to be considered during HB-HTA process.
Methodology for integrating health technology assessment into decision-making

Jing-song GENG,Ying-yao CHEN,Bo-sheng WU,Yuan HUANG

2014-01-01

Abstract:The modes of integrating health technology assessment(HTA)into national decision-making in UK and Canada were systematically analyzed. Methodology of bridging HTA with decision-making,including models of evidence and value combination,and tools for HTA adaptation were investigated. It was proposed that HTA should play a critical role in government healthcare decision-making. It was also proposed that an evidence-based,open,transparent and stakeholder-involved HTA model should be established. Furthermore,methodological system regarding application of HTA in various settings of decision-making was suggested to be explored in future research.
Outcomes of guidelines from health technology assessment organizations in community-based primary care: a systematic mixed studies review

Ashkan Baradaran,Raymond Tolentino,Roland Grad,Isabelle Ganache,Geneviève Gore,Samira Abbasgholizadeh Rahimi,Pierre Pluye

DOI: https://doi.org/10.1017/s0266462324000370

2024-11-24

International Journal of Technology Assessment in Health Care

Abstract:Background Health technology assessment (HTA) organizations generate guidelines to inform healthcare practices toward improved health outcomes. This review sought to identify and classify outcomes of guidelines from HTA organizations within published research. Methodology We performed a systematic mixed studies review of empirical studies that (a) referred to a published guideline from an HTA organization and (b) reported an outcome resulting from a guideline. We searched the published literature in English or French within seven databases. Outcome types were classified within five dimensions of an existing framework for online health information (e.g., relevance, cognitive/affective impact, and use). Subdimensions were inductively developed. A two-phase sequential data synthesis was performed. Phase 1: a hybrid deductive–inductive thematic analysis identified the types of outcomes and displayed their relationships on a concept map. Phase 2: descriptive statistics were tabulated by the type of outcome. Results A total of 6,719 records were retrieved through searches on 6 February 2023. After screening, we included 120 observational studies (twenty-one qualitative, ninety-four quantitative, and five mixed methods). Phase 1 identified twenty-nine types of outcomes. The most frequently reported outcomes were within the organizational dimension (reported in ninety-four studies). The most common subdimensions were "Referrals" (thirty-eight occurrences), the "Quality of Prescriptions" (fifteen occurrences), and the "Quality of Diagnosis" (eight occurrences). For Phase 2, we could only generate descriptive statistics on seventeen outcomes. These were almost equally distributed among positive, neutral, and negative effects. Our results contribute to knowledge about the outcomes of HTA guidelines and options for documenting and measuring them in future evaluations.

public, environmental & occupational health,health care sciences & services,medical informatics
The Early Experiences of Ileorectal Anastomosis

R. Corbett,M. Chir

DOI: https://doi.org/10.1177/00359157590520S110

1959-01-01

Proceedings of the Royal Society of Medicine

Abstract:Following operation she did well for five days, after which she began to complain of lower Abdominal pain, although the ileostomy continued to work well. These symptoms continued and were accompanied by a rising pulse-rate which finally reached 110, and a temperature of 10060 6 F. On the ninth post-operative day, severe left upper quadrant pain occurred with tenderness and spasticity. The wound opened slightly and a musty odor was detected. Immediate operation was performed and a gas gangrene infection was found with some necrosis of the rectus muscle, but with intact peritoneum. The wound was opened widely, necrotic tissue debrided, and Dakin's tubes laid into the two sides of the wound through which a continuous wet dressing of hydrogen peroxide was maintained. Large doses of penicillin were administered intravenously. The patient slowly recovered and is now healthy and happy, with wounds healed and ileostomy functioning perfectly. BIBLIOGRAPHY 1 BANKS, B. M., KORELITZ, B. I., and ZETZEL, L. (1957) Gastroenterology, 32, 983. 2 BARGEN, J. A., JACKMAN, R. J., and KERR, J. G. (1938) Ann. intern. Med., 12, 399. 3 CATTELL, R. B. (1953) Amer. J. Surg., 86, 613. 4 CROHN, B. B., GARLOCK, J. H., and YARNIS, H. (1947) J. Amer. med. Ass., 134, 334. 5 DUKES, C. E. (1954) Ann. R. Coll. Surg. Engl., 14, 389. 6 RIPSTEIN, C. B. (1953)J. Amer. med. Ass., 152, 1093. 7 SCARBOROUGH, R. A. (1955) Amer. J. Surg., 89, 1224. 8 WARREN, S. (1957) Gastroenterology, 83, 399. 9 , and SOMMERS, S. C. (1954) J. Amer. med. Ass., 154,189.

A sporadic case of central core disease.

Health Technology Assessment and Its Use in Drug Policies in China

Functional Mechanism(s) of the Inhibition of Disease Progression by Combination Treatment with Fingolimod Plus Pathogenic Antigen in a Glucose-6-phosphate Isomerase Peptide-Induced Arthritis Mouse Model.

OP27 Health Technology Assessment Processes, Characteristics, And Key Differences In High, Middle, And Low-Income Countries Of Asia Pacific Region

The Development of Health Technology Assessment in Asia: Current Status and Future Trends.

Differences In Evaluating Health Technology Assessment Knowledge Translation By Researchers And Policy Makers In China

Title : Voice Processing Abilities in Children with Autism Children with Specific Language Impairments and Young Typically Developing Children

Development of Health Technology Assessment in China: New Challenges

[Comparative characteristics of types of medical technologies assessment]

Health Technology Assessment of Medical Devices: Current Landscape, Challenges, and a Way Forward

Comparative analysis of knowledge translation of health technology assessment research between different types of research institues

Health Technology Assessment Development In China

Development of Health Technology Assessment in Singapore,South Korea and Japan:Overview and Implications for China

Mapping of Health Technology Assessment in China: Situation Analysis and International Comparison

Are Medical Device Characteristics Included in HTA Methods Guidelines and Reports? A Brief Review

The Health Technology Assessment Environment in Mainland China, Japan, South Korea, and Taiwan—Implications for the Evaluation of Diabetes Mellitus Therapies

Health technology assessment and economic evaluation: Is it applicable for the traditional medicine?

Analysis on guiding principles of hospital-based health technology assessment

Methodology for integrating health technology assessment into decision-making

Outcomes of guidelines from health technology assessment organizations in community-based primary care: a systematic mixed studies review

The Early Experiences of Ileorectal Anastomosis